4//SEC Filing
Birznieks Gunther 4
Accession 0000950170-25-032281
CIK 0001347178other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:46 PM ET
Size
4.7 KB
Accession
0000950170-25-032281
Insider Transaction Report
Form 4
Birznieks Gunther
SVP, Business Development
Transactions
- Tax Payment
Common Stock
2025-03-01$4.76/sh−26,941$128,239→ 411,628 total
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001702031
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:46 PM ET
- Size
- 4.7 KB